anthrarufin has been researched along with chrysophanic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, CY; Huang, SS; Yeh, SF | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Matsuda, H; Morikawa, T; Shimoda, H; Yoshikawa, M | 1 |
| Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T | 1 |
| Choowongkomon, K; Eurtivong, C; Jiwacharoenchai, N; Niwetmarin, W; Ruchirawat, S; Saruengkhanphasit, R; Seetaha, S | 1 |
1 review(s) available for anthrarufin and chrysophanic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
4 other study(ies) available for anthrarufin and chrysophanic acid
| Article | Year |
|---|---|
Effect of anthraquinone derivatives on lipid peroxidation in rat heart mitochondria: structure-activity relationship.
Topics: Animals; Anthraquinones; Antioxidants; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Male; Mitochondria, Heart; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1995 |
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
Topics: Anthraquinones; Cell Division; Cells, Cultured; Emodin; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Genistein; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Polygonaceae; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship | 2001 |
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones | 2021 |
Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; ErbB Receptors; Heterocyclic Compounds; Humans; Molecular Docking Simulation; Molecular Structure; National Cancer Institute (U.S.); Oxygen; Protein Kinase Inhibitors; Structure-Activity Relationship; United States; Xanthenes | 2022 |